A toxic failed drug resurrected. So toxic the original company abandoned any testing on molnupiravir. Whistleblower reports warning the HHS and others are all over the web. Read them now before they are scrubbed. It sure is good to be BP in a corrupt system.
Ridgeback's Molnupiravir failed its cliniacal trial for hospitalized patients with moderate to severe covid.It was halted by Merck after the FDA asked for additional information.